Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Options

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Nov 26, 2023 7:24pm

138 Views

Post# 35753691

RE:RE:RE:Options

I believe you are correct, Canadafan.

But this will be by far the biggest share purchase by MC and KL.

150,000 * $1.45 =. A lot of money even for someone grossly overcompensated like MC and KL.

And it is a lot of money to be investing in a crappy micro cap biotech.

I do hope they hold on to every single share, else the message to the market is a huge negative stain for the company.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China